Tislelizumab,Sorafenib
BeiGene,bayer
['tislelizumab', 'beigene', '$bgne']
$bgne new article : beigene announces data presentations at esmo 2022 including late-breaking oral presentation for tislelizumab in first-line unresectable hepatocellular cancer get all the latest $bgne related news here : 
We’ll make staying up-to-date on top of your investments easy for you. Create a free account and get real-time financial news updates for your portfolio!